Gami Apoor S, Friedman Paul A, Chung Mina K, Caples Sean M, Somers Virend K
Division of Cardiovascular Diseases, Mayo Clinic College of Medicine, MN 55905, USA.
Nat Clin Pract Cardiovasc Med. 2005 Mar;2(3):145-9. doi: 10.1038/ncpcardio0130.
Atrial fibrillation (AF) and obesity are coinciding epidemics. Obstructive sleep apnea (OSA) correlates directly with obesity and is highly prevalent among middle-aged adults. Emerging evidence supports a strong association between AF and OSA. The rate of AF among patients with OSA is low but is nevertheless higher than that in the general population. The prevalence of OSA among patients with AF is strikingly high-at least 32% and possibly as high as 49%-although differences in the AF populations studied and the criteria used to diagnose OSA have prevented more accurate measurement of this rate. Data in focused populations at risk of AF show that OSA increases the frequency and recurrence of AF. These findings cannot, however, be reliably generalized to the larger OSA population. Although the available information is limited, treatment of OSA, particularly with continuous positive airway pressure, seems to substantially reduce the frequency of AF. If true, this approach would provide a safe and noninvasive therapy for some patients with AF. Randomized controlled trials are necessary to rigorously answer this question. Many data have been obtained from studies with focuses other than the direct relationship between OSA and AF. Studies carefully designed to investigate the relevant issues are now needed.
心房颤动(AF)和肥胖是同时存在的流行病。阻塞性睡眠呼吸暂停(OSA)与肥胖直接相关,在中年成年人中非常普遍。新出现的证据支持AF与OSA之间存在密切关联。OSA患者中AF的发生率较低,但仍高于一般人群。AF患者中OSA的患病率极高——至少为32%,可能高达49%——尽管所研究的AF人群以及用于诊断OSA的标准存在差异,使得无法更准确地测量这一比率。针对有AF风险的特定人群的数据表明,OSA会增加AF的发作频率和复发率。然而,这些发现无法可靠地推广到更大的OSA人群。尽管现有信息有限,但对OSA的治疗,尤其是采用持续气道正压通气治疗,似乎能大幅降低AF的发作频率。如果这是真的,那么这种方法将为一些AF患者提供一种安全且无创的治疗手段。需要进行随机对照试验来严格回答这个问题。许多数据来自于并非聚焦于OSA与AF直接关系的研究。现在需要精心设计研究来调查相关问题。